Anticoccidial Market Forecasted to Reach USD 4.3 Billion By 2035, at an Impressive 3.35% CAGR
Chemical Anticoccidials are valued at USD 1.0 billion in 2024 and forecasted to hit USD 1.45 billion by 2035.
US, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Global Anticoccidial Market Set to Reach USD 4.3 Billion by 2035 Amid Growing Demand for Livestock Health SolutionsAccording to the latest analysis by Market Research Future (MRFR), the Global Anticoccidial Market valued at USD 2.9 billion in 2023, is projected to grow to USD 4.3 billion by 2035, expanding at a CAGR of 3.35% from 2025 to 2035. This growth is propelled by rising global demand for protein-rich diets, increasing awareness of animal health, and the surge in livestock and poultry production.
Get your copy now by clicking here:
https://www.marketresearchfuture.com/sample_request/42953
Market Overview
Coccidiosis continues to be a critical concern for livestock producers worldwide, with the global push toward efficient, sustainable farming creating an urgent need for robust anticoccidial solutions. Regulatory support, increasing preference for antibiotic-free products, and growing R&D investment have positioned anticoccidial products as essential tools in modern animal husbandry.
Buy it now by visiting here:
https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=42953
Market Drivers
Rising Demand for Poultry Products: Global population growth and higher disposable income have increased the consumption of meat and eggs, necessitating effective disease management.
Supportive Regulatory Frameworks: Governments and health agencies are actively promoting the adoption of veterinary solutions to improve livestock health and ensure food safety.
Expansion in Livestock Farming: Especially in developing regions, the integration of modern farming practices has spurred the need for effective parasite control.
Key Market Trends
Shift Toward Sustainable Farming: The global movement toward antibiotic-free meat is influencing product innovation and adoption of bio-based anticoccidial alternatives.
Technological Advancements: New tools for disease monitoring and the use of probiotics and vaccines are becoming central to coccidiosis prevention strategies.
Emerging Markets Opportunity: Asia Pacific and South America present significant growth potential due to increasing poultry consumption and agricultural expansion.
Segmentation Highlights
By Product Type:
Ionophore Anticoccidials dominate the market with an estimated valuation of USD 1.5 billion in 2024, projected to reach USD 2.15 billion by 2035.
Chemical Anticoccidials are valued at USD 1.0 billion in 2024 and forecasted to hit USD 1.45 billion by 2035.
Vaccines, while smaller at USD 0.49 billion, are growing steadily with a projected value of USD 0.7 billion by 2035, indicating a rise in preventative approaches.
By Application:
Poultry remains the largest consumer of anticoccidial products, followed by cattle, swine, and aquaculture.
By Administration Route:
Oral remains the most commonly used method, while injection and topical routes are gaining ground for their targeted efficacy.
By Formulation:
The market supports various formats including powder, liquid, granular, and premix, with powder dominating due to ease of use.
Regional Insights
North America leads the market with an expected valuation of USD 1.7 billion by 2035.
Europe follows at USD 1.2 billion, with strong regulatory support and high product adoption.
Asia-Pacific is emerging rapidly, expected to reach USD 1.1 billion, fueled by population growth and rising meat consumption.
South America and MEA remain nascent but promising, projected to grow to USD 0.25 billion each by 2035.
Key Players in the Market
Prominent companies driving innovation and expansion in the Anticoccidial Market include:
Cegelec
BASF
Merck & Co.
Cargill
Neovia
Chr. Hansen
De Heus
Alltech
Boehringer Ingelheim
Huvepharma
Elanco Animal Health
Phibro Animal Health
Kemin Industries
Virbac
Zoetis
Recent Developments
Major players such as Zoetis and Merck & Co. have expanded their R&D initiatives to launch next-gen vaccines and drug formulations. Strategic alliances, such as those between Alltech and Cargill, are strengthening market presence, while mergers and acquisitions continue to shape the competitive landscape—evidenced by Elanco’s ongoing portfolio diversification.
Related MRFR Reports with Full Detailed Analysis:
India Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/india-automatic-pill-dispenser-market-45444
Italy Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/italy-automatic-pill-dispenser-market-45442
South America Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/south-america-automatic-pill-dispenser-market-45443
Spain Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/spain-automatic-pill-dispenser-market-45446
Uk Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/uk-automatic-pill-dispenser-market-45439
Us Automatic Pill Dispenser Market: https://www.marketresearchfuture.com/reports/us-automatic-pill-dispenser-market-15679
China Behavioral Health Services Market: https://www.marketresearchfuture.com/reports/china-behavioral-health-services-market-45486
Gcc Behavioral Health Services Market: https://www.marketresearchfuture.com/reports/gcc-behavioral-health-services-market-45481
Germany Behavioral Health Services Market: https://www.marketresearchfuture.com/reports/germany-behavioral-health-services-market-45480
India Behavioral Health Services Market: https://www.marketresearchfuture.com/reports/india-behavioral-health-services-market-45485
Market Research Future
Market Research Future
+1 855-661-4441
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

LAICA Elevates Home Healthcare with Innovative Solutions for Everyday Well-Being
Healthy Horizons CEO and COO Recognized for Maternal Health and STEM Advocacy with Stevie® Awards
Interscan Corporation Hosts Live Webinar on Navigating New EPA Ethylene Oxide Regulations for Healthcare Sterilization
Kalendarium
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Prawo

400 gmin w Polsce nie ma na swoim terenie apteki i sytuacja co roku się pogarsza. Samorządowcy apelują o zmiany w prawie
W ciągu ostatnich kilku lat, od wejścia w życie przepisów Apteka dla Aptekarza, zamknięto ponad 2,2 tys. aptek w Polsce, a około 400 gmin nie posiada na swoim terenie apteki. Trzech na pięciu Polaków, aby kupić leki, musi się udać po nie do innej miejscowości. Sygnatariusze listu otwartego do minister zdrowia przygotowanego przez Koalicję „Na pomoc niesamodzielnym” apelują o zmianę priorytetów w legislacji dotyczącej rynku aptek. Wzywają też do podjęcia systemowych działań przeciwdziałających wykluczeniu zdrowotnemu ze względu na miejsce zamieszkania.
Bankowość
1 mln zł na innowacyjne rozwiązania dla miast. Granty mogą otrzymać naukowcy i start-upy

Niskoemisyjny transport, oszczędzanie zasobów, zarządzanie odpadami czy walka z zanieczyszczeniami – to część wyzwań, które stawia przed miastami szybko rosnąca liczba mieszkańców. Na przynajmniej część z nich odpowiedzią mogą być innowacje, które mogą pomóc także w adaptacji miast do zmiany klimatu. To właśnie innowacyjnych rozwiązań wspierających zrównoważony rozwój miast poszukuje ING Bank Śląski w nowej edycji Programu Grantowego. Do młodych naukowców i start-upów trafi 1 mln zł.
Telekomunikacja
Obciążenia regulacyjne uderzają w branżę nowych technologii i start-upy. To może hamować innowacje

Nadmierne obciążenia biurokratyczne i wysokie koszty prawne są wskazywane przez wiele start-upów jako bariery, które są najtrudniejsze do pokonania w ich działalności – wynika z raportu „Polskie Startupy 2024”. To sprawia, że część z nich szuka możliwości przeprowadzki za ocean – ze stratą dla innowacyjności i konkurencyjności polskiej gospodarki. Również w branży ICT o potrzebie deregulacji mówi się od lat, bo to przeszkadza jej w globalnym wyścigu technologicznym.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.